Pless J., Bauer W., Briner U. et al. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin. Scand J Gastroenterol1986; 21 (suppl 119): 54-64.
2.
Nightingale Jmd, Walker ER, Burnham WR et al. Short bowel syndrome. Digestion1990; 45 (suppl 1): 77-83.
3.
Jacobsen O., Ladefoged K., Stage JG, Jarnum S.Effects of cimetidine on jejunostomy effluents in patients with severe short-bowel syndrome. Scand J Gastroenterol1986; 21: 824-28.
4.
Ladefoged K. , Christensen KC, Hegnhoj J., Jarnum S.Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome . Gut1989; 30: 943-49.
5.
Reichlin S.Somatostatin. N Engl J Med1983; 309: 1495-1501.
6.
Nubiola Calonge P., Sancho J., Segura M. et al. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output. Lancet1987; ii: 672-74.
7.
Boden G., Sivitz MC, Owen OE et al. Somatostatin suppresses secretin and pancreatic exocrine secretion . Science1975; 160: 163-65.
8.
Bloom SR, Mortimer CH, Thorner MO et al. Inhibition of gastrin and gastric acid secretion by GH-RIH. Lancet1974; ii: 1106-1109.
9.
Thor P., Krol R., Kontureck JJ et al. Effect of somatostatin on myoelectrical activity of small bowel . Am J Physiol1978; 235: 249-54.
